[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
AbbVie's $1.2B acquisition of Bretisilocin from Gilgamesh is a major deal in psychedelic M&A, sparking discussions about the pharma industry's role in keeping people sick. Investment firms like TANG Capital and RA Capital are actively disclosing their Q325 holdings, with $GHRS appearing in several portfolios.
$GHRS is a cryptocurrency project focused on advancements in therapeutic research.
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
X Week: XXXXX +59%
X Month: XXXXXX +17%
X Months: XXXXXXX -XX%
X Year: XXXXXXXXX +140%
1-Year High: XXXXXXX on 2025-02-03
1-Year Low: X on 2025-12-07
Engagements by network (24h): X: XXXXX
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XX -XX%
X Month: XXX +32%
X Months: XXXXX +84%
X Year: XXXXX +319%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-12-07
Mentions by network (24h): X: XXX
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $ghrs in the last XX hours which is up XX% from X in the previous XX hours
Daily Average: XX
X Week: XX -XX%
X Month: XX +7.40%
X Months: XXX +240%
X Year: XXXXX +381%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-12-07
The most influential creators that mention $ghrs in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @PsychedVantage | X | XXXXX | X | XXX |
| @flobrand | X | XXXXX | X | XXX |
| @seedytx19 | X | XXXXX | X | XX |
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
X Week: XXX% +25%
X Month: XXX% no change
X Months: XXX% +40%
X Year: XXX% no change
1-Year High: XXX% on 2024-12-12
1-Year Low: XX% on 2025-06-10
Most Supportive Themes:
Most Critical Themes:
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"listen and learn about the biggest psychedelic M&A deal of the year AbbVies $1.2B acquisition of IP of Bretisilocin from psy drug developer Gilgamesh financial disclosure: tweet author participated in the seed round of Gilgamesh during COVID"
X Link @psy_dao 2025-12-09T20:33Z 16.6K followers, 1039 engagements
"Psychedelic Biotech in 2025: What's Next @flobrand and @LarsWilde $ATAI $CMPS $MNMD $CYBN $GHRS"
X Link @PsychedVantage 2025-12-09T17:01Z 1662 followers, 6150 engagements
"Big X publicly trade companies are $CMPS $MNMD $CYBN $ATAI and $GHRS. You can make an argument that $DRUG is a psychedelic stock with their earlier stage programs. You also have Solvonis Therapeutics Tryptamine Therapeutics (I think they changed their name again to something else) BetterLife Pharma Clearmind Medicine and Enveric Biosciences. Outside of $CMPS $MNMD $CYBN $ATAI $GHRS and $DRUG the rest are nano caps. I am personally most bullish on $ATAI and $CYBN as I hold shares in both. But if you asked me which companies I am most bullish on in short term medium term and longterm I would"
X Link @PsychedVantage 2025-12-07T00:44Z 1663 followers, XXX engagements
"2025 has been quite the year for the psychedelic drug development sector: $CMPS $MNMD $CYBN $ATAI $GHRS We have seen positive mid-late stage data coming from multiple companies across a variety of compounds targeting multiple indications. Nearly $XXX million has been raised in follow-on offerings in the past several months and of course big pharma has acquired a compound in the space (and may I add one that doesn't skip the trip) So what do we have to look forward to in 2026 This post will focus on clinical trial readouts: $CMPS to disclose 9-week data (Part A) from COMP006 together with"
X Link @PsychedVantage 2025-12-06T19:28Z 1663 followers, 1540 engagements